Oxidative stress and its involvement in the development and course of urinary system diseases in children
Abstract
The paper presents data on free radical oxidation as a universal physiological process in the cell. In health, at the low concentrations of reactive oxygen species under the control of the antioxidant system, these are involved in the regulation of vascular tone and immune defense and act as second messengers to transmit signals across the cell membrane. Urinary system diseases develop oxidative stress. The reactive oxygen species are shown to be involved in the regulation of extracellular matrix metabolism, apoptosis, by contributing to the development of nephrosclerosis and the progression of chronic kidney disease. Many aspects of free radical reactions in urinary system diseases in children require that they should be investigated using current direct control methods. There is a need for further development of new approaches to combination treatment using antioxidant agents in children with for urinary system diseases.
References
1. Valko М., Morrig Н., Cronin M.T. Metals, toxicity and oxidative stress. CurrMedChem2005; 12: 1161—1208.
2. Меныцикова Е.Б., Зенков Н.К., Панкин В.З. и др. Окислительный стресс: патологические состояния и заболевания. Новосибирск: Сибирское университетское изд-во 2008; 284. (Men'shhikova E.B., Zenkov N.K., Lankin V.Z. et al. Oxidative stress: pathological conditions and diseases. Novosibirsk: Sibirskoe universitetskoe Publ 2008; 284.)
3. Ray P.D. Huang B. W., Tsuii Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012; 24: 5: 981-990.
4. Белоцкий СМ., Авталион P.P. Воспаление. Мобилизация клеток и клинические эффекты. М: Изд-во БИНОМ 2008; 240. (Belockij S.M., Avtalion R.R. Inflammation. Cell mobilization and clinical effects. Moscow: BINOM Publ 2008; 240.)
5. Владимиров Ю.А. Свободные радикалы в биологических системах. Соросовский образовательный журн 2000; 6: 13—19. (Vladimirov Ju.A. Free radicals in biological systems. Sorosovskij obrazovaternyj zliurn 2000; 6: 13—19.)
6. Дубинина Е.Е. Продукты метаболизма кислорода в функциональной активности клеток (жизнь и смерть, созидание и разрушение). Физиологические и клинико-биохи-мические аспекты. Ст-Петербург: Медицинская пресса 2006; 400. (Dubinina E.E. Products of oxygen metabolism in the functional activity of the cells (the life and death, creation and destruction). Physiological and biochemical aspects of the clinical. St-Petersburg: Medicinskajapressa2006; 400.)
7. Locatelli E, Canaud В., Eckardt K.-U. et al. Oxidative stress in end stage renal disease: an emerging threat to patient outcome nephrol dial trasplantant. Nephrol 2003; 18:7: 1272—1280.
8. Подопригорова В.Е. Оксидативный стресс и язвенная болезнь. М: Медицина 2004; 176. (Podoprigorova V.G. Oxidative stress and peptic ulcer disease. Moscow: Medicina 2004; 176.)
9. ИгнатоваМ.С, КоровжаНА. Диагностика и лечение нефро-патий у детей. М: ГЭОТАР-Медиа 2007; 336. (Ignatova M.S., Korovina NA. Diagnosis and treatment of nephropathy in children. Moscow: GE'OTAR-Media2007; 336.)
10. Инфекция мочевой системы у детей. Под ред. В.В. Длина, И.М. Османова, О.Л. Чугуновой и др. М: ООО «М Арт» 2011; 384. (Urinary tract infection in children. V.V. Dlin, I.M. Osmanov, O.L. Chugunova et al. (eds.). Moscow: OOO «M-Art» 2011; 384.)
11. Баранов А.А. Состояние здоровья детей в Российской Федерации. Педиатрия 2012; 3: 9—14. (Baranov A.A. The health of children in the Russian Federation. Pediatrija 2012; 3: 9-14.)
12. Бухарин О.В., Вялкова А.А., Ериценко В.А. Клинико-ми-кробиологической обоснование ранней диагностики пиелонефрита у детей. Рос педиат журн 2003; 2: 42—47. (Buharin O.V., Vjalkova A.A., Gricenko V.A. Clinico-microbiological study of early diagnosis of pyelonephritis in children. Ros pediat zhurn 2003; 2: 42—47.)
13. Сергеева Т.В. Инфекция мочевыводящих путей у детей.
14. Вопр соврем педиат 2002; 4: 49—53. (Sergeeva T.V. Urinary tract infection in children. Vopr sovrem pediat 2002; 4:49—53.)
15. Cohen A.L., Rivara F.P., Davis R., Christakis D.A. Compliance with guidelines for the medical care of first urinary tract infections in infants. Pediatrics 2005; 115: 6: 1474—1478.
16. Мальцев СВ., Мансурова Е.Ш., Полетаев А.Б. Естественные нефротропнные антитела как прогностический показатель заболевания пиелонефритом у детей. Вопр диагн в педиат 2009; 1: 3: 52—57. (Mal'cev S.V., Mansurova G.Sh., Poletaev A.B. Renotrophic natural antibodies as a prognostic indicator of disease pyelonephritis in children. Vopr diagn v pediat 2009; 1:3: 52-57.)
17. Пекарева Н.А., Чупрова А.В., Лоскутова С А. Патогенетическое значение изучения динамики цитокинов при хроническом обструктивном пиелонефрите у детей. Педиатрия 2008; 87: 3: 23—27. (Pekareva N.A., Chuprova A.V., Loskutova S.A. Pathogenetic importance of studying the dynamics of cytokines in chronic obstructive pyelonephritis in children. Pediatrija 2008; 87: 3: 23—27.)
18. Аполихин О.П., Сивков А.В., Москалева НЕ. и др. Анализ уронефрологической заболеваемости детей в РФ по данным официальной статистики (1999—2009 гг.). Экспе-рим и клин урол 2011; 4: 4—11. (Apolihin O.L, Sivkov A.V., Moskaleva N.G. Analysis uronefrologicheskoy incidence of children in the Russian Federation according to official statistics (1999—2009). Jeksperimiklinurol2011; 4: 4—11.)
19. Тугушева Ф.А., Зубина И.М. Оксидативный стресс и его участие в неиммунных механизмах прогрессирования хронической болезни почек. Нефрология 2009; 13: 3: 42—48. (Tugusheva FA., Zubina I.M. Oxidative stress and its participation in non-immune mechanisms of progression of chronic kidney disease. Nefrologiya 2009; 3: 13: 42—48.)
20. Еолод Е.А., Кирпатовский В.И. Роль кислородных радикалов в нарушениях метаболизма в почках больных острым и хроническим пиелонефритом. Патологическая физиология и экспериментальная терапия 2006; 1: 23—27. (Golod E.A., Kirpatovskij V.I. The role of oxygen radicals in metabolic disorders in the kidneys of patients with acute and chronic pyelonephritis. Patologicheskaja fiziologija ijeksperimentarnajaterapij 2006; 1: 23—27.)
21. Коровина НА., Захарова И.Н. Лечение хронического ту-булоинтерстициального нефрита у детей. Педиатрия 2008; 87: 3: 86—90. (KorovinaN.A., Zaharoval.N. Treatment of chronic tubulointerstitial nephritis in children. Pediatrija 2008; 3: 87: 86-90.)
22. Khan S.R. Stress oxidative: nephrolithiasis and chronic kidney diseases. Minerva Med 2013; 104: 1: 23—30.
23. Pavlova E.L., Litova M.I., Savov V.M. Oxidative stress in children with kidney disease. Pediatr nephrol 2005; 20: 11: 1599-1604.
24. Возианов А.Ф., Майданник В.Е, Бидный В.Е. и др. Основы нефрологии детского возраста. Киев: Книга плюс 2002; 348. (Vozianov A.E, Majdannik V.G., Bidnyj V.G. et al. Fundamentals ofpediatric nephrology. Kiev: Knigapljus 2002; 348.)
25. Захарова И.Н., Свинцицкая В.И. Применение витаминов-антиоксидантов в педиатрической практике. Лечащий врач 2010; 8: 45—47. (Zaharoval.N., SvincickajaV.I. The use of vitamins-antioxidant in the pediatric. Lech vrach 2010; 8: 45—47.)
26. Bulbul M., Oner A., Demircin G. et al. Oxidative stress in children with acute glomerulonephritis. Renal failure 2008; 30: 2: 209-214.
27. Приезжева Е.Ю., Лебедько О.А. Особенности оксида-тивного статуса у детей с хроническим течением пиелонефрита в стадии обострения и ремиссии на фоне врожденных пороков развития органов мочевой системы. Дальневосточный мед журн 2009; 2: 67—69. (Priezzheva E.Yu., Lebed'ko O.A. Peculiarities oxidative status in children with chronic pyelonephritis in the acute stage and remission background of congenital malformations of the urinary system. Dal'nevostochnyj med zhurn 2009; 2: 67—69.)
28. Araujo M., Welch W.J. Oxidative stress and nitric oxide in function. CurropinNephrolHypertens2006; 15: 1: 72—77.
29. Fine L.G., Norman J.T. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008; 74: 7: 867—872.
30. Bondi CD., Manickam N, Lee D.Y. et al. NAD(P)H oxidase mediates TGF-Pj-induced activation of kidney myofibroblasts. J Am Soc Nephrol 2010; 21: 93-102.
31. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 2: 199-210.
32. Massy Z.A., Nguyen-Knoa T. Oxidative stress and chronic renal failure: markers and management. J Nephrol 2002; 15: 336-341.
33. Zwolinska D. Oxidative stress in children on peritoneal dialysis. Perit Dial 2009; 29: 2: 171-177.
34. Manucha W., Valles P.G. Apoptosis modulated by oxidative stress and inflammation during obstructive nephropathy. Infiamm Allergy Drug Targets 2012; 11: 4: 303—312.
35. Nlandu Khodo S., Dizin E., Sossauer G. et al. NADP-oxidase 4 protect against kidney fibrosis during chronic renal injury. JAm Soc Nephrol 2012; 12: 1967-1976.
36. Kashihara N, Sugiyama R., Makino H. Implication of apoptosis in progression of renal disease. Nephrol 2003; 139: 156-172.
37. Vaziri N.D., Dicus M., Ho N.D. et al. Oxidative stress and dys-regulation of superoxide dismutase a NADPH dismutase in renal insufficiency. Kidney Int 2003; 63: 179—185.
38. Ruggenenti P., Pagano E., Tammuzzo L. et al. Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies. Kidney Int 2001; 59: 286-294.
39. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol 2007; 18: 2439-2446.
40. Zhou S.Y., Xiao W, Pan X.J. et al. Thrombin promotes human lung fibroblasts to proliferate via NADPH oxidase/reactive oxygen species/extracellular regulated kinase signaling pathway. Chin Med J 2010; 123: 2432—2439.
41. Sampson N, Koziel R., Zenzmaier C. et al. ROS signaling by N0X4 drives fibroblast-to-myofibroblast differentiation
42. in the diseased prostatic stroma. Mol Endocrinol 2011; 25: 503-515.
43. Barnes J.L., Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 2011; 79: 944—956.
44. Forbes J.M., Cough Ian M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008; 57: 1446-1454.
45. Hua P., Feng W, Ji S. et al. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol 2010; 299: 732-739.
46. LuoX., FangS., Xiao Y. etal. Cyanidin-3-glucoside suppresses TNF-alpha-induced cell proliferation through the repression of Nox activator 1 in mouse vascular smooth muscle cells: involvement of the STAT3 signaling. Mol Cell Biochem 2012; 362:211-218.
47. Zhang Y, Peng F., Gao B. et al. High glucose-induced RhoA activation requires caveolae and PKCbetal-mediated ROS generation. Am J Physiol Renal Physiol 2012; 302: 159—172.
48. Kim E.Y., Anderson M., Dryer S.E. Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species. Am J Physiol Renal Physiol 2012; 302: 298-307.
49. Cao W., Zhou Q.G., Nie J. et al. Albumin overload activates intrarenal renin-angiotensin system through protein kinase С and NADPH oxidase- dependent pathway. J Hypertens 2011; 29:1411-1421.
50. WolfG., Wenzel U., Hannken T. et al. Angiotensin II induces p27(Kipl) expression in renal tubules in vivo: role of reactive oxygen species. J Mol Med (Berl) 2001; 79: 382—389.
51. Catania J.M., Gben G., Parrisb A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 2007; 292: 905-911.
52. Leung J.C. Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone. JTransl Med 2011; 9: 169.
53. Liu Y. Advanced oxidation protein products: a causative link between oxidative stress and podocyte depletion. Kidney Int 2009; 76: 1125-1127.
54. GuoZ.J., NiuH.X., HouF.F. et al. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal 2008; 10: 1699-1712.
55. Zhou L.L., Hou F.F., Wang G.B. et al. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int 2009; 76: 1148—1160.
56. Wei X.F., Zhou Q.G., Hou F.F. et al. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 2009; 296: 427-437.
57. Nistala R., Whaley-Connell A., Sowers J.R. Redox control of renal function and hypertension. Antioxid Redox Signal 2008; 10: 2047-2089.
Review
For citations:
Pleshkova E.M. Oxidative stress and its involvement in the development and course of urinary system diseases in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(5):9-14. (In Russ.)
Views:
686
Email this article 